IBEX (IBEX) CEO Dechant sells 12,000 common shares in market

Rhea-AI Filing Summary

IBEX Ltd Chief Executive Officer and director Robert Thomas Dechant reported open-market sales of company common shares on two consecutive days. He sold 6,000 common shares on February 17 at a weighted average price of $29.6310 per share and another 6,000 shares on February 18 at a weighted average price of $29.9756 per share.

Both transactions were executed as multiple trades within stated price ranges, with detailed trade-level information available on request. Following these sales, Dechant directly owns 293,406 IBEX common shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dechant Robert Thomas

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	02/17/2026		S		6,000	D	$29.631(1)	299,406	D
Common Shares	02/18/2026		S		6,000	D	$29.9756(2)	293,406	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $29.35 to $30.16; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

2. This transaction was executed in multiple trades at prices ranging from $29.535 to $30.27; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did IBEX (IBEX) report for Robert Thomas Dechant?

IBEX reported that Chief Executive Officer Robert Thomas Dechant sold a total of 12,000 common shares in two open-market transactions. These sales occurred on February 17 and February 18 and were reported on a Form 4 insider trading disclosure for IBEX Ltd.

How many IBEX (IBEX) shares did the CEO sell and on which dates?

Robert Thomas Dechant sold 6,000 IBEX common shares on February 17 and another 6,000 shares on February 18. Both transactions were classified as open-market sales of non-derivative common shares according to the Form 4 filing data.

At what prices did the IBEX (IBEX) CEO sell his common shares?

The February 17 sale had a weighted average price of $29.6310 per share, while the February 18 sale had a weighted average price of $29.9756. Each day’s transaction was executed in multiple trades within stated price ranges disclosed in the Form 4 footnotes.

How many IBEX (IBEX) shares does the CEO hold after these insider sales?

After the reported sales, Robert Thomas Dechant directly owns 293,406 IBEX common shares. The Form 4 indicates this post-transaction holding following the February 18 open-market sale of 6,000 common shares by the company’s Chief Executive Officer.

What do the Form 4 footnotes reveal about the IBEX (IBEX) insider trades?

The footnotes state each transaction was executed in multiple trades within specified price ranges, and the reported prices are weighted averages. They also note the reporting person will provide full trade-by-trade pricing details to the issuer, shareholders, or SEC staff upon request.

Were the IBEX (IBEX) CEO’s transactions direct or through another entity?

The filing classifies the CEO’s ownership as direct, with the ownership code "D" and no nature-of-ownership footnote indicating an intermediary entity. This means the 12,000 shares sold and the remaining 293,406 shares are reported as directly held by Robert Thomas Dechant.